Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATTNYSEARCA:PINNYSE:TAM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/APINInvesco India ETF$24.69+3.5%$24.30$23.07▼$31.17$225.67M0.8453,837 shs64,976 shsTAM(TAM)$0.00$18.95▼$26.96N/AN/A330,661 shsN/AReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%PINInvesco India ETF+3.52%-1.75%+4.97%-3.74%-9.33%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/APINInvesco India ETFN/AN/AN/AN/AN/AN/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/APINInvesco India ETF 0.00N/AN/AN/ATAM(TAM) 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/APINInvesco India ETFN/AN/AN/AN/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/APINInvesco India ETFN/AN/A24.25∞N/AN/AN/AN/AN/ATAM(TAM)N/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/APINInvesco India ETF$2.198.87%N/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/APINInvesco India ETFN/ATAM(TAM)N/AInsider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/APINInvesco India ETFN/ATAM(TAM)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionablePINInvesco India ETFN/A9.14 millionN/ANot OptionableTAM(TAM)N/AN/AN/ANot OptionableTAM, BHMU, PIN, and ATT HeadlinesRecent News About These CompaniesTam Union school district picks new superintendentApril 8 at 10:40 AM | msn.comHGC Strengthens International Business Leadership with More Focused Roles for Cliff Tam and Ravindran MahalingamApril 3, 2025 | sinchew.com.myThink XRP (Ripple) Is Expensive? This Chart Might Change Your Mind.April 2, 2025 | finance.yahoo.comPreps of the week: Lee, Clark lead the way for surging TamApril 1, 2025 | msn.com🌱 Tam High sports teams dominate local competitionsApril 1, 2025 | msn.comPrep softball: Tam’s early season vibes continue with win against Terra LindaMarch 30, 2025 | msn.comUT Dallas student arrested after allegedly assaulting two other students with bike lockMarch 29, 2025 | msn.comPrep softball: Tam’s early-season vibes continue with win against Terra LindaMarch 29, 2025 | msn.comMicrosoft Partner Chief Dezen: Solution Providers ‘Touch Every Stage Of The Customer Journey’March 28, 2025 | crn.comTamron Hall thanks 'Tam Fam' as show celebrates 1,000th episodeMarch 28, 2025 | 6abc.comSports Briefs: Mill Valley’s McCormack earns national attentionMarch 28, 2025 | marinij.comTam Union parents push back on ethnic studies accessMarch 28, 2025 | marinij.comTam Development Co.March 24, 2025 | argaam.comCustoms House Museum wins 5 awards at Tennessee Association of Museums conferenceMarch 21, 2025 | clarksvillenow.comInterview: Tam Mutu in TAKE THE LEAD at Paper Mill PlayhouseMarch 18, 2025 | broadwayworld.comArt Museum of Eastern Idaho announces “Off-the-Wall Art Sale”March 18, 2025 | localnews8.comThe Audio Marketplace (TAM) Website is Now LiveMarch 18, 2025 | afp.comSimplot company foundation supports local Art Museum expansionMarch 13, 2025 | localnews8.com10 Common Mistakes B2B Marketers Make When Measuring TAMMarch 13, 2025 | marketingprofs.comFree speech group sues Texas A&M over decision to ban drag shows across university systemMarch 11, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Short Sellers Wrong About These 3 Semiconductor Stocks?By Leo Miller | April 4, 2025View Are Short Sellers Wrong About These 3 Semiconductor Stocks?Best of Both Worlds: 3 ETFs With High Dividend Yields, Low FeesBy Nathan Reiff | March 26, 2025View Best of Both Worlds: 3 ETFs With High Dividend Yields, Low FeesD-Wave: Multiple Use Cases Emerge Following Quantum SupremacyBy Nathan Reiff | April 1, 2025View D-Wave: Multiple Use Cases Emerge Following Quantum SupremacyTariffs, Spin-Out, and R2 Updates Are Positive Signs for RivianBy Leo Miller | April 3, 2025View Tariffs, Spin-Out, and R2 Updates Are Positive Signs for RivianAmazon Stock Bounces From Lows as Smart Money Steps InBy Sam Quirke | April 9, 2025View Amazon Stock Bounces From Lows as Smart Money Steps InTAM, BHMU, PIN, and ATT Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.Invesco India ETF NYSEARCA:PIN$24.69 +0.84 (+3.52%) As of 04/9/2025 04:10 PM EasternPowerShares India Portfolio (the Fund) is based on the Indus India Index (Index). The Fund seeks to achieve its investment objective by investing substantially all of its assets in a wholly-owned subsidiary located in the Republic of Mauritius (the Subsidiary), which in turn invests at least 90% of its total assets in securities of Indian companies that consists of the Index, as well as American depositary receipts(ADR) and global depositary receipts (GDR) based on the securities in the Index. The Index is designed to represent the segment of the Indian equity markets. The Funds sectors allocations include consumers discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials and telecommunication services. Invesco PowerShares Capital Management LLC serves as investment adviser the Fund.(TAM) NYSE:TAMTaminco Corp is a producer of alkylamines and alkylamine derivatives. The Company's products are used by its customers in the manufacturing of everyday products primarily for the agriculture, water treatment, personal and home care, animal nutrition and oil and gas end-markets. It operates in 19 countries with seven production facilities and, as of December 31, 2012, had an installed production capacity of 1,272 thousand tons. The Company has three business segments: Functional Amines, Specialty Amines, and Crop Protection. In March 2014, the Company announced that it completed the acquisition of the formic acid business of Kemira Oyj. Its main shareholder is Eastman Chemical Company. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Alphabet a Generational Buying Opportunity at These Levels? Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop? Harley-Davidson Tops Watchlists: Value Trap or Turnaround Play? Strategy’s $5 Million Bitcoin Target: Beacon or Bagholder? Amazon Stock Bounces From Lows as Smart Money Steps In Qualcomm Breaks Down But RSI Signals It’s Severely Oversold Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy Will CrowdStrike's Goodwill Strategy Pay Off in Revenue Gains? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
